Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
56
ATXS Quote, Financials, Valuation and Earnings
Last price:
$13.01
Seasonality move
:
28.87%
Day range:
$12.86 - $13.04
52-week range:
$3.56 - $13.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1,061.67x
P/B ratio:
5.38x
Volume:
660.3K
Avg. volume:
1.3M
1-year change:
36.06%
Market cap:
$742.7M
Revenue:
--
EPS (TTM):
-$2.15
Earnings Data
Next earnings date for ATXS
Mar 18
2026
Most recent earnings per share
-$0.55
Missed by $0.12
(Nov 12/2025)
Consensus Estimate
-$0.42
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ATXS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/18/2026 | Q4 | $400K | -- | -- | -$0.46 | -- |
| 11/12/2025 | Q3 | $10.7M | $706K | -$0.55 | -$0.42 | -$0.12 |
| 08/12/2025 | Q2 | -- | -- | -$0.57 | -$0.58 | $0.01 |
| 05/08/2025 | Q1 | -- | -- | -$0.58 | -$0.48 | -$0.10 |
| 03/11/2025 | Q4 | -- | -- | -$0.45 | -- | -- |
| 11/13/2024 | Q3 | -- | -- | -$0.42 | -- | -- |
| 08/12/2024 | Q2 | -- | -- | -$0.43 | -- | -- |
| 05/09/2024 | Q1 | -- | -- | -$0.38 | -- | -- |
| 03/04/2024 | Q4 | -- | -- | -$0.94 | -- | -- |
| 11/13/2023 | Q3 | -- | -- | -$0.63 | -- | -- |
| 08/07/2023 | Q2 | -- | -- | -$0.45 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.40 | -- | -- |
| 03/22/2023 | Q4 | -- | -- | -$0.72 | -- | -- |
| 11/10/2022 | Q3 | -- | -- | -$0.87 | -- | -- |
| 08/09/2022 | Q2 | -- | -- | -$0.86 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$1.18 | -- | -- |
| 03/10/2022 | Q4 | -- | -- | $3.23 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.61 | -- | -- |
| 08/09/2021 | Q2 | -- | -- | -$5.33 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$45.60 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$2.64 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$3.36 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$3.18 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$3.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$3.30 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$3.36 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$3.72 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$3.72 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$3.48 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$4.80 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$11.88 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$17.28 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$13.92 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$18.60 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$19.20 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$24.60 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$27.00 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$32.40 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$36.60 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$36.60 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$37.80 | -- | -- |
Astria Therapeutics, Inc. Earnings Questions
-
How Much did Astria Therapeutics, Inc. Generate in Revenue Last Quarter?
Astria Therapeutics, Inc. reported $706K worth of top line sales in its most recent quarter.
-
Did Astria Therapeutics, Inc. Beat Earnings Last Quarter?
Astria Therapeutics, Inc. announced earnings per share of -$0.55 which represents a miss of analyst forecast a -$0.42 per share.
-
Is Astria Therapeutics, Inc. Profitable?
Astria Therapeutics, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Astria Therapeutics, Inc. EPS Next Year?
Astria Therapeutics, Inc.'s earnings are forecast to decrease from -$1.68 per share to -$1.95 per share next year representing a decrease of -26.51%.
-
When is Astria Therapeutics, Inc.'s Earnings Date?
Astria Therapeutics, Inc.'s next earnings date is March 18, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
